ARTICLE | Clinical News
Quizartinib: Phase III started
October 17, 2016 7:00 AM UTC
Daiichi began the double-blind, placebo-controlled, international Phase III QuANTUM-First trial to evaluate quizartinib plus induction and consolidation chemotherapy and as maintenance monotherapy in ...